Risks of Arboviral Infections for Rituximab Patients

Risks Associated with Arboviral Infections in Rituximab-Treated Patients Patients undergoing rituximab therapy, a monoclonal antibody known for depleting B-cells, face elevated risks of neuroinvasive diseases and mortality when infected with arboviral pathogens. The true incidence of infections and related fatalities may be underestimated due to the challenging and costly molecular testing often necessary for identifying … Read more